JP6267239B2 - 極めて低粘度の新規エステル化セルロースエーテル - Google Patents

極めて低粘度の新規エステル化セルロースエーテル Download PDF

Info

Publication number
JP6267239B2
JP6267239B2 JP2015560340A JP2015560340A JP6267239B2 JP 6267239 B2 JP6267239 B2 JP 6267239B2 JP 2015560340 A JP2015560340 A JP 2015560340A JP 2015560340 A JP2015560340 A JP 2015560340A JP 6267239 B2 JP6267239 B2 JP 6267239B2
Authority
JP
Japan
Prior art keywords
cellulose ether
esterified cellulose
viscosity
esterified
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2015560340A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016516835A (ja
JP2016516835A5 (enExample
Inventor
オリヴァー・ピーターマン
ロバート・ビー・アッペル
マインオルフ・ブラックハーゲン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Global Technologies LLC
Original Assignee
Dow Global Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies LLC filed Critical Dow Global Technologies LLC
Publication of JP2016516835A publication Critical patent/JP2016516835A/ja
Publication of JP2016516835A5 publication Critical patent/JP2016516835A5/ja
Application granted granted Critical
Publication of JP6267239B2 publication Critical patent/JP6267239B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B13/00—Preparation of cellulose ether-esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/20—Post-etherification treatments of chemical or physical type, e.g. mixed etherification in two steps, including purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2015560340A 2013-03-07 2014-02-28 極めて低粘度の新規エステル化セルロースエーテル Expired - Fee Related JP6267239B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361774161P 2013-03-07 2013-03-07
US61/774,161 2013-03-07
PCT/US2014/019266 WO2014137778A1 (en) 2013-03-07 2014-02-28 Novel esterified cellulose ethers of very low viscosity

Publications (3)

Publication Number Publication Date
JP2016516835A JP2016516835A (ja) 2016-06-09
JP2016516835A5 JP2016516835A5 (enExample) 2016-11-04
JP6267239B2 true JP6267239B2 (ja) 2018-01-24

Family

ID=50439471

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015560340A Expired - Fee Related JP6267239B2 (ja) 2013-03-07 2014-02-28 極めて低粘度の新規エステル化セルロースエーテル

Country Status (7)

Country Link
US (1) US9617351B2 (enExample)
EP (1) EP2964204B1 (enExample)
JP (1) JP6267239B2 (enExample)
KR (1) KR101661952B1 (enExample)
CN (1) CN105025887B (enExample)
BR (1) BR112015015846A2 (enExample)
WO (1) WO2014137778A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6356923B2 (ja) * 2015-03-16 2018-07-11 ダウ グローバル テクノロジーズ エルエルシー 水溶性エステル化セルロースエーテル
WO2016148976A1 (en) * 2015-03-16 2016-09-22 Dow Global Technologies Llc Gelling esterified cellulose ethers
EP3270971B1 (en) * 2015-03-16 2019-01-09 Dow Global Technologies LLC Water-soluble esterified cellulose ethers having a low degree of neutralization
US20180071396A1 (en) * 2015-03-16 2018-03-15 Dow Global Technologies Llc Aqueous solution of an esterified cellulose ether
WO2016148975A1 (en) * 2015-03-16 2016-09-22 Dow Global Technologies Llc A process for fractionating an esterified cellulose ether
MX2017011091A (es) * 2015-03-16 2017-11-10 Dow Global Technologies Llc Proceso para preparar un eter de celulosa esterificado en presencia de un acido carboxilico alifatico.
EP3463314B1 (en) 2016-05-25 2020-07-22 Dow Global Technologies LLC Aqueous solution of cellulose ether acetate
US10888525B2 (en) * 2016-11-02 2021-01-12 Shin-Etsu Chemical Co., Ltd. Hypromellose acetate succinate and method for producing the same
WO2018170060A1 (en) 2017-03-17 2018-09-20 Dow Global Technologies Llc Process for recovering an esterified cellulose ether from a reaction product mixture
WO2018170062A1 (en) 2017-03-17 2018-09-20 Dow Global Technologies Llc Process for recovering an esterified cellulose ether from a reaction product mixture
WO2018170083A1 (en) 2017-03-17 2018-09-20 Dow Global Technologies Llc Process for recovering an esterified cellulose ether from a reaction product mixture

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4819231B1 (enExample) 1970-03-06 1973-06-12
US4226981A (en) 1977-09-28 1980-10-07 Shin-Etsu Chemical Co., Ltd. Ether-ester derivatives of cellulose and their applications
US4365060A (en) 1979-04-28 1982-12-21 Shin-Etsu Chemical Co. Ltd. Enterosoluble capsules
JPS59167521A (ja) * 1983-03-14 1984-09-21 Shin Etsu Chem Co Ltd 腸溶性コ−テイング剤組成物
JPS6281402A (ja) 1985-10-07 1987-04-14 Shin Etsu Chem Co Ltd セルロ−スエ−テル酸性ジカルボン酸エステルの製造方法
JP3149122B2 (ja) 1994-11-07 2001-03-26 信越化学工業株式会社 固形腸溶製剤のコーティング用基剤
JPH10167959A (ja) * 1996-12-04 1998-06-23 Zensei Yakuhin Kogyo Kk ジクロフェナクナトリウムの徐放性カプセル製剤
EP0872233A1 (en) 1997-04-14 1998-10-21 Janssen Pharmaceutica N.V. Antiretroviral compositions with improved bioavailability
ATE364374T1 (de) 1997-08-11 2007-07-15 Pfizer Prod Inc Feste pharmazeutische dispersionen mit erhöhter bioverfügbarkeit
KR100387126B1 (ko) * 2001-04-19 2003-06-12 삼성정밀화학 주식회사 히드록시프로필메틸 셀룰로오스 프탈레이트의 분리정제방법
DE10141680B4 (de) * 2001-08-25 2004-02-26 Clariant Gmbh Verfahren zur Herstellung niederviskoser Celluloseether durch sauer-oxidativen Abbau von gemahlenen und getrockneten Celluloseethern
SI1517899T1 (sl) 2002-05-17 2008-02-29 Tibotec Pharm Ltd Substituirani benzoksazol sulfonamidi sirokega spektra, ki so HIV proteazni inhibitorji
CN1681479A (zh) 2002-08-12 2005-10-12 辉瑞产品公司 半有序药物和聚合物的药物组合物
WO2005115330A2 (en) 2004-05-28 2005-12-08 Pfizer Products Inc. Pharmaceutical compositions with enhanced performance
KR101597992B1 (ko) * 2007-11-09 2016-02-26 유니온 카바이드 케미칼즈 앤드 플라스틱스 테크날러지 엘엘씨 초저점도 셀룰로스 에테르의 제조 방법 및 생성물
US8920553B2 (en) 2007-11-09 2014-12-30 Dow Global Technologies Llc Cellulose ether coating compositions and method
CN101965186A (zh) 2007-11-28 2011-02-02 塞阔伊亚药品公司 抑制细胞色素p450 2d6的化合物和方法
JP5322740B2 (ja) 2009-04-01 2013-10-23 国立大学法人東京農工大学 有害生物防除方法
BR112012031667A2 (pt) 2010-06-14 2016-11-08 Dow Global Technologies Llc composição
US20120251588A1 (en) * 2011-03-30 2012-10-04 Miyuki Fukasawa Coating Composition, Solid Preparation Coated Therewith, and Method for Preparing Solid Preparation
JP2015512456A (ja) 2012-03-27 2015-04-27 ダウ グローバル テクノロジーズ エルエルシー セルロースエーテルのエステルの製造方法
EP2836205B1 (en) * 2012-04-11 2016-10-19 Dow Global Technologies LLC Esterified cellulose ethers having a specific substituent distribution
KR102138545B1 (ko) * 2012-08-24 2020-07-28 다우 글로벌 테크놀로지스 엘엘씨 고분자량 및 높은 균일성을 갖는 신규한 에스테르화된 셀룰로즈 에테르
US9745387B2 (en) * 2012-08-24 2017-08-29 Dow Global Technologies Llc Partially cross-linked esterified cellulose ethers
JP6215945B2 (ja) 2012-08-24 2017-10-18 ダウ グローバル テクノロジーズ エルエルシー 新規ヒドロキシアルキルメチルセルロースアセテートサクシネート

Also Published As

Publication number Publication date
CN105025887B (zh) 2017-07-28
BR112015015846A2 (pt) 2017-07-11
JP2016516835A (ja) 2016-06-09
US20150376299A1 (en) 2015-12-31
CN105025887A (zh) 2015-11-04
US9617351B2 (en) 2017-04-11
KR20150119472A (ko) 2015-10-23
WO2014137778A1 (en) 2014-09-12
KR101661952B1 (ko) 2016-10-04
EP2964204B1 (en) 2017-01-04
EP2964204A1 (en) 2016-01-13

Similar Documents

Publication Publication Date Title
JP6321688B2 (ja) 低粘度の新規エステル化セルロースエーテル
JP6267239B2 (ja) 極めて低粘度の新規エステル化セルロースエーテル
JP6321689B2 (ja) 新規の低粘度及び高分子量のエステル化セルロースエーテル
JP6334574B2 (ja) 新規の超高分子量のエステル化セルロースエーテル
JP6224711B2 (ja) 部分架橋結合型エステル化セルロースエーテル
JP6420520B2 (ja) 新規の高分子量及び高均一性のエステル化セルロースエーテル

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150827

A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A529

Effective date: 20150827

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150827

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20150827

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20160615

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160621

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20160624

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20160629

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20160629

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20160912

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20161018

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170117

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20170127

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20170217

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20171221

R150 Certificate of patent or registration of utility model

Ref document number: 6267239

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees